← Back to Search

Smoking Cessation E-Visit for Quitting Smoking (INSPIRE Trial)

N/A
Recruiting
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6
Awards & highlights
No Placebo-Only Group

Summary

This trial will evaluate an online questionnaire to help people quit smoking, with potential to receive a prescription for a smoking cessation medication. Participants will complete questionnaires & provide breath samples over a 24 week period.

Who is the study for?
This trial is for adults who smoke at least 5 cigarettes daily, have been smoking regularly for over 6 months, and are not currently using any quit-smoking treatments. Participants must live where they can get mail, speak English, use or be willing to sign up for Epic's MyChart program, check their email daily, and own a smartphone compatible with the study's breath sample app.
What is being tested?
The study is testing an online e-visit system designed to help people stop smoking in rural primary care settings. Some participants will receive this e-visit intervention while others will continue with usual care. The e-visit includes questions about smoking habits and may lead to a prescription for quitting aids but doesn't require taking medication.
What are the potential side effects?
There might be no direct side effects from participating in the e-visits themselves; however, if participants choose to take prescribed cessation medications as a result of the e-visit recommendation, they could experience side effects associated with those specific drugs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reduction in Cigarettes Per Day
Smoking Cessation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Smoking cessation electronic visit (e-visit)Experimental Treatment1 Intervention
This group will be sent 1) an invitation to complete an electronic visit (e-visit) focused on cigarette smoking and 2) an invitation to complete a follow-up e-visit one-month after the initial e-visit.
Group II: Treatment as usual (TAU)Active Control1 Intervention
This group will be provided information about the state quitline and about the importance of quitting smoking and it will be recommended that they contact their PCP to schedule a medical visit to discuss quitting smoking.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking cessation e-visit
2019
N/A
~60

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
972 Previous Clinical Trials
7,399,014 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,925 Previous Clinical Trials
41,017,713 Total Patients Enrolled

Media Library

Smoking cessation e-visit Clinical Trial Eligibility Overview. Trial Name: NCT05764759 — N/A
Smoking Cessation Research Study Groups: Smoking cessation electronic visit (e-visit), Treatment as usual (TAU)
Smoking Cessation Clinical Trial 2023: Smoking cessation e-visit Highlights & Side Effects. Trial Name: NCT05764759 — N/A
Smoking cessation e-visit 2023 Treatment Timeline for Medical Study. Trial Name: NCT05764759 — N/A
~165 spots leftby Feb 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top